Skip to main content
. 2021 Jan 13;14:379–392. doi: 10.2147/OTT.S288709

Table 1.

Correlation Between mRNA Expression of SLC6A14 and Clinical Characteristics in 82 CRC Patients

Variables No. of Patients SLC6A14 Expression P-value
High Group
(n=41)
Low Group
(n=41)
Gender
 Male 39 20 19 0.8250
 Female 43 21 22
Age
 <50 40 23 17 0.2692
 ≥50 42 18 24
Tumor grade
 G1+G2 45 23 22 0.8244
 G3+G4 37 18 19
Tumor invasion
 T1+T2 39 17 22 0.3766
 T3+T4 43 24 19
Size (cm)
 <5 35 14 21 0.1800
 ≥5 47 27 20
Lymph node status
 Negative 34 10 24 0.0033**
 Positive 48 31 17
TNM stage
 I+II 36 12 24 0.0139*
 III+IV 46 29 17

Notes: *P < 0.05. **P < 0.01.